Marubeni Construction Material Lease Co.,Ltd. Logo

Marubeni Construction Material Lease Co.,Ltd.

Leases and sells temporary steel materials and offers engineering for major construction projects.

9763 | T

Overview

Corporate Details

ISIN(s):
JP3878000003
LEI:
Country:
Japan
Address:
港区芝公園2丁目4番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Marubeni Construction Material Lease Co., Ltd. specializes in the leasing, sale, repair, and processing of temporary steel materials for the construction industry. The company's core product portfolio includes sheet piles, H-beams, steel supports, and steel decks. In addition to material provision, its engineering division offers planning and design services for temporary steel structures. The firm primarily supports the development of urban infrastructure and large-scale construction projects.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-11 02:19
Interim Report
確認書
Japanese 9.8 KB
2025-11-11 02:18
Interim Report
半期報告書-第58期(2025/04/01-2025/09/30)
Japanese 211.2 KB
2025-06-23 06:28
Post-Annual General Meeting Information
臨時報告書
Japanese 27.0 KB
2025-06-18 05:01
Registration Form
確認書
Japanese 10.1 KB
2025-06-18 05:00
Governance Information
内部統制報告書-第57期(2024/04/01-2025/03/31)
Japanese 28.5 KB
2025-06-18 04:59
Annual Report
有価証券報告書-第57期(2024/04/01-2025/03/31)
Japanese 1.1 MB
2024-11-12 05:08
Interim Report
確認書
Japanese 9.4 KB
2024-11-12 05:06
Interim Report
半期報告書-第57期(2024/04/01-2025/03/31)
Japanese 205.8 KB
2024-06-21 02:39
Post-Annual General Meeting Information
臨時報告書
Japanese 25.4 KB
2024-06-20 06:56
Registration Form
確認書
Japanese 9.5 KB
2024-06-20 06:55
Governance Information
内部統制報告書-第56期(2023/04/01-2024/03/31)
Japanese 24.8 KB
2024-06-20 06:31
Registration Form
有価証券報告書-第56期(2023/04/01-2024/03/31)
Japanese 1.1 MB
2024-02-09 03:40
Quarterly Report
確認書
Japanese 9.4 KB
2024-02-09 03:39
Quarterly Report
四半期報告書-第56期第3四半期(2023/10/01-2023/12/31)
Japanese 182.3 KB
2023-11-13 05:18
Quarterly Report
確認書
Japanese 9.4 KB

Automate Your Workflow. Get a real-time feed of all Marubeni Construction Material Lease Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Marubeni Construction Material Lease Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Marubeni Construction Material Lease Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CIZZLE BIOTECHNOLOGY HOLDINGS PLC Logo
Developing a CIZ1B biomarker blood test for the early detection of lung cancer.
United Kingdom
CIZ
Clear Channel Outdoor Holdings, Inc. Logo
An OOH ad platform connecting brands to consumers via digital billboards and data analytics.
United States of America
CCO
CODEXIS, INC. Logo
Engineering high-performance enzymes for pharma, diagnostics, and life science manufacturing.
United States of America
CDXS
Cogent Biosciences, Inc. Logo
Developing precision small molecule therapies for cancers, autoimmune, and rare diseases.
United States of America
COGT
COMPASS Pathways plc Logo
Developing psilocybin therapies for severe mental health challenges like TRD and PTSD.
United States of America
CMPS
COMSCORE, INC. Logo
Cross-platform audience measurement and media analytics for advertisers, publishers, and agencies.
United States of America
SCOR
COPRO-HOLDINGS. Co., Ltd. Logo
Dispatches technical personnel to Japan's construction & plant industries.
Japan
7059
Corbus Pharmaceuticals Holdings, Inc. Logo
Clinical-stage oncology company developing targeted therapies like ADCs for cancer and obesity.
United States of America
CRBP
Corvus Pharmaceuticals, Inc. Logo
Develops novel, targeted therapies for immune diseases and cancer.
United States of America
CRVS
Coya Therapeutics, Inc. Logo
Developing Treg-modulating therapies for neurodegenerative and autoimmune diseases.
United States of America
COYA

Talk to a Data Expert

Have a question? We'll get back to you promptly.